S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
24,000
-1,500 (-5.88%)
Last updated: Mar 28, 2025

S.Biomedics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
271,328203,202130,376---
Upgrade
Market Cap Growth
55.86%55.86%----
Upgrade
Enterprise Value
272,607206,789133,226---
Upgrade
Last Close Price
23100.0017300.0011500.00---
Upgrade
PS Ratio
19.3414.809.95---
Upgrade
PB Ratio
22.8711.1010.55---
Upgrade
P/TBV Ratio
17.7417.7418.92---
Upgrade
EV/Sales Ratio
19.8515.0610.16---
Upgrade
Debt / Equity Ratio
1.031.030.9713.331.781.17
Upgrade
Asset Turnover
0.360.360.470.570.500.26
Upgrade
Inventory Turnover
2.992.993.335.146.186.07
Upgrade
Quick Ratio
2.202.201.670.753.191.96
Upgrade
Current Ratio
2.492.492.050.953.442.12
Upgrade
Return on Equity (ROE)
-37.96%-37.96%-138.29%-195.41%-121.47%-97.95%
Upgrade
Return on Assets (ROA)
-8.89%-8.89%-13.30%-11.13%-16.13%-26.13%
Upgrade
Return on Capital (ROIC)
-11.07%-11.07%-19.11%-18.41%-27.49%-38.11%
Upgrade
Earnings Yield
-2.47%-3.29%-7.92%---
Upgrade
FCF Yield
-1.80%-2.41%-6.13%---
Upgrade
Buyback Yield / Dilution
-5.15%-5.15%-6.98%-0.67%-0.42%-3.93%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.